Skip to content

3Accepted Feb 12, 9:29 PM ET

Avicenna Life Sci Master Fund LP 3

LXRXLEXICON PHARMACEUTICALS, INC.

Accepted (ET)

9:29 PM

Feb 12, 2026

Filed

Feb 12, 2026

Documents

1

Size

8.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.